Cholesterol deposits under the eyes, known medically as xanthelasma palpebrarum, do not go away on their own and almost always require a procedure to remove. The most effective options range from surgical excision and chemical peels to laser ablation, each with its own trade-offs in cost, scarring risk, and recurrence rate. Before choosing a treatment, it helps to understand what these yellowish plaques really are, why they form, and what their presence might signal about your broader health.
What Xanthelasma Actually Is
Xanthelasma appears as soft, flat or slightly raised yellowish patches on or around the eyelids, most often near the inner corners. The patches are painless and grow slowly over months or years. Under a microscope, they consist of lipid-laden immune cells, particularly macrophages that have gorged on cholesterol and transformed into what pathologists call “foam cells.” These foam cells accumulate in the upper layer of the skin, giving the lesion its characteristic buttery color.
The tissue is also surprisingly inflamed. Biopsy studies show that xanthelasma samples contain far more T lymphocytes and macrophages than normal eyelid skin, with roughly twice as many T cells and more than five times as many macrophages in the affected tissue compared with healthy controls.1PubMed Central. Inflammatory Mediators in Xanthelasma Palpebrarum: Histopathologic and Immunohistochemical Study That chronic inflammatory environment helps explain why xanthelasma tends to persist and recur: the underlying process is more active than the quiet appearance of the plaques suggests.
The Cholesterol Connection, and When It Is Missing
Most people assume xanthelasma is a straightforward sign of high cholesterol, and there is truth to that. In one study of 80 patients with these eyelid deposits, about 80 percent had some form of abnormal blood lipids, whether elevated total cholesterol, high LDL, high triglycerides, or low HDL.2PubMed Central. Dyslipidemia in Patients with Xanthelasma Palpebrarum Visiting the Department of Dermatology of a Tertiary Care Centre: A Descriptive Cross-sectional Study Genetic research supports a causal link: a large Mendelian randomization study found that genetically higher levels of total cholesterol and LDL cholesterol were significantly associated with xanthelasma, while triglycerides, blood pressure, blood sugar, and body mass index were not.3PubMed Central. Causal associations between plasma lipids, metabolic traits, circulating proteins, and xanthelasma palpebrarum: a Mendelian randomization study
That said, roughly one in five people with xanthelasma has entirely normal cholesterol on a standard blood panel. These “normolipidemic” cases puzzled researchers for years, but the explanation appears to involve subtler lipid abnormalities. When researchers compared xanthelasma patients who had normal cholesterol levels with matched controls, they found that the patients still had higher levels of apolipoprotein B, the protein that carries LDL particles, and lower levels of apolipoprotein A1, which is protective.4Postgraduate Medical Journal. Xanthelasma palpebrarum: a marker of premature atherosclerosis (risk of atherosclerosis in xanthelasma) In other words, even when standard cholesterol numbers look fine, the lipid transport machinery may be tilted in a direction that favors cholesterol deposition in the skin and, potentially, in blood vessel walls.
Surgical Excision
For most dermatologists and oculoplastic surgeons, cutting the deposits out remains the gold standard, especially for larger or deeper lesions. The procedure is done under local anesthesia, and for smaller plaques it is straightforward: the surgeon removes the yellowish tissue, and the wound is closed with fine sutures. For bigger lesions that span a significant portion of the eyelid, the surgeon may combine the excision with a local skin flap or a small skin graft, sometimes harvested from excess eyelid skin during a simultaneous blepharoplasty.
Outcomes from surgical series are generally good. In a study of 95 patients, about 70 percent were treated with simple excision alone, while a quarter needed local flaps and a small number required skin grafts. The recurrence rate was around 3 percent, and only about 4 percent of patients developed scar contracture that needed a follow-up procedure.5PubMed Central. Outcomes of surgical management of xanthelasma palpebrarum More recent surgical techniques using subcutaneous debridement of the flap have also produced natural-looking eyelids with minimal scarring and low recurrence.6PubMed Central. Aesthetic Surgical Treatment of Large Xanthelasma palpebrarum
A broad review of the surgical literature found that combining excision with blepharoplasty and skin grafts yielded particularly strong results for large xanthelasma. In several series, no recurrences were noted at more than six months of follow-up, though occasional hyperpigmentation of the graft site was reported. When reconstruction used a mix of local flaps and skin grafts, recurrence rates ranged from about 3 to 8 percent over six to twelve months.7PubMed Central. A Practical Review of the Management of Xanthelasma palpebrarum The main downside of surgery is the recovery period and the possibility of visible scarring, although in experienced hands the incisions tend to hide well in the natural eyelid creases.
Trichloroacetic Acid Peels
If you would rather avoid a scalpel, one of the most studied nonsurgical options is a concentrated chemical peel using trichloroacetic acid (TCA) at 80 percent strength. The acid is applied directly to the xanthelasma under controlled conditions, essentially burning away the lipid-laden tissue layer by layer. This is not something you do at home; TCA at that concentration requires careful application by a trained practitioner to avoid damaging surrounding skin or, worse, the eye itself.
The results are encouraging for an office-based procedure. In a study tracking 77 patients, clinicians reported visible improvement in over 97 percent of those assessed, and about 94 percent of patients said they were satisfied with their outcome.8PubMed Central. Treatment of Xanthelasma Palpebrarum Using Trichloroacetic Acid 80 Side effects were relatively mild: some temporary redness, swelling, and crusting in the days after treatment, with a small percentage experiencing longer-term hyperpigmentation or hypopigmentation. Scarring occurred in a few patients but was uncommon.
Recurrence, however, is the catch. In a follow-up questionnaire, about a quarter of patients reported that their xanthelasma came back at some point after TCA treatment.9Journal of Clinical and Aesthetic Dermatology. Treatment of Xanthelasma Palpebrarum Using Trichloroacetic Acid 80% Repeat sessions are often needed, which can be both a feature and a drawback: TCA is relatively inexpensive and quick to perform, so retreating is not a major burden, but some people understandably find the idea of repeated acid applications to their eyelids unappealing.
Laser Treatments
Lasers offer another way to destroy the cholesterol-laden tissue without a traditional incision. The two most commonly used types are the carbon dioxide (COâ‚‚) laser and the erbium:YAG (Er:YAG) laser, both of which work by vaporizing tissue in thin, controlled layers. A randomized trial that split treatment between eyelids on the same patients found that the COâ‚‚ laser produced excellent improvement faster: by the fourth visit, about 90 percent of COâ‚‚-treated sides showed excellent results compared with roughly 63 percent of Er:YAG-treated sides. Over a follow-up period of one to two years, however, recurrence rates were similar at around 22 to 24 percent for both laser types.10PubMed. A Comparison of Efficacy and Safety of Fractional Carbon Dioxide Laser and Fractional Er:YAG Laser for the Treatment of Xanthelasma Palpebrarum: A Two-Center Randomized Split-Face Controlled Trial
The Er:YAG laser tends to be gentler on surrounding tissue. Because it ablates more shallowly per pulse, it generally leads to less post-treatment redness, quicker healing, and fewer pigmentation changes than the COâ‚‚ laser.11PubMed Central. Er:YAG Laser Therapy for Xanthelasma Palpebrarum: A Retrospective Case Series Evaluating Clinical Efficacy, Safety, and Patient Outcomes in Periocular Lesion Management That makes it a reasonable choice if you are particularly concerned about visible healing or have darker skin that is more prone to pigmentation shifts. On the other hand, you may need more sessions with the Er:YAG to achieve the same clearance. The choice between the two often comes down to how quickly you want results versus how much downtime and side-effect risk you are willing to accept.
Other Approaches
A handful of additional methods appear in the dermatology literature, though none has the same depth of evidence as surgery, TCA, or lasers. Liquid nitrogen cryotherapy freezes the xanthelasma tissue, which then blisters and sloughs off over the following week or two. The technique is quick and inexpensive, but precise depth control is difficult around the thin eyelid skin, raising the risk of pigmentation changes and incomplete removal. Electrocautery uses a heated needle tip to destroy the deposits and is sometimes combined with curettage (scraping). Both cryotherapy and electrocautery are described in treatment reviews alongside the more studied modalities.12PubMed Central. Xanthelasma: An Update on Treatment Modalities
More experimental options include intralesional injections of agents designed to dissolve the lipid deposits or stimulate local remodeling, but published data on these remains thin. For now, these are not mainstream recommendations, and anyone offered one should ask about the evidence base and the practitioner’s experience with it.
Recurrence Is the Central Frustration
No matter which treatment you choose, recurrence is the single biggest challenge with xanthelasma. The deposits come back in a substantial minority of cases, and the recurrence rate does not seem to vary dramatically between methods. One study that followed patients across different treatment approaches found an overall recurrence rate of about 18 percent, with no significant difference between surgical, chemical, and other techniques.13Annals of Plastic Surgery. Relationship Between Xanthelasma Palpebrarum and Hyperlipidemia Individual studies report figures ranging from as low as 3 percent to as high as 25 percent, depending on the method, follow-up duration, and how deeply the original lesion extended.
Why do they come back? The inflammatory and lipid-deposition process that created the original xanthelasma does not stop just because the visible plaque was removed. If the underlying metabolic environment remains the same, new foam cells can accumulate in the same area. Deeper lesions and those that involve the underlying muscle seem to carry higher recurrence risk after nonsurgical treatments, because chemical peels and lasers may not reach the full depth of the deposit. Larger and bilateral lesions also tend to recur more often.
Will Lowering Your Cholesterol Make Them Disappear?
This is one of the most common questions, and the honest answer is: probably not, with a rare but notable exception. Standard lipid-lowering medications like statins can improve your blood lipid profile and reduce cardiovascular risk, but they generally do not cause existing xanthelasma to shrink or vanish. The cholesterol trapped in those foam cells is already deposited and sequestered in the skin; lowering the amount of cholesterol circulating in your blood does not efficiently reverse what has already been laid down.
There is, however, at least one dramatic case report involving alirocumab, a newer and more powerful cholesterol-lowering drug in the PCSK9 inhibitor class. A middle-aged man with genetically driven severe high LDL cholesterol had large xanthelasma on both eyelids despite years of treatment with statins and ezetimibe. After 26 months on alirocumab, the deposits disappeared entirely, something that had not been previously reported with any lipid-lowering drug in that patient population.14PubMed. Rapid resolution of xanthelasmas after treatment with alirocumab This is a single case, not a clinical trial, so it would be premature to count on cholesterol medication to resolve your xanthelasma. But it does suggest that very aggressive lipid lowering may sometimes help, particularly in people whose cholesterol levels were extremely high to begin with.
Regardless of whether medication shrinks the plaques, getting your lipids checked and treated is still worthwhile for a different reason: your heart.
What Xanthelasma Signals About Heart Disease Risk
Beyond being a cosmetic annoyance, xanthelasma is an independent marker of cardiovascular risk. Research from the Copenhagen General Population Study found that xanthelasma predicted the risk of heart attack, ischemic heart disease, severe atherosclerosis, and death in the general population, even after adjusting for traditional cardiovascular risk factors like cholesterol levels, blood pressure, smoking, and diabetes.15PubMed Central. Cardiovascular Profile of Xanthelasma Palpebrarum This association holds even in the subset of patients who have normal cholesterol, likely because of the subtler apolipoprotein abnormalities described earlier.4Postgraduate Medical Journal. Xanthelasma palpebrarum: a marker of premature atherosclerosis (risk of atherosclerosis in xanthelasma)
The practical takeaway: if you develop xanthelasma, treat it as a prompt to get a thorough cardiovascular workup. That means not just a basic cholesterol panel but ideally an assessment of apolipoprotein levels, and a conversation with your doctor about your overall cardiovascular risk profile. Even if your total cholesterol and LDL numbers are in the normal range, the xanthelasma itself is telling you something worth investigating.
Choosing a Treatment
There is no single best treatment for everyone. Your choice depends on the size and depth of the deposits, your tolerance for downtime, your skin type, and how much the cosmetic result matters to you relative to cost and convenience. A few practical considerations that may help:
- Small, shallow deposits: TCA peels or laser ablation are reasonable first-line options. They are office-based, relatively quick, and leave minimal scarring when performed carefully. Multiple sessions may be needed.
- Large or deep deposits: Surgical excision, sometimes combined with a local flap or skin graft, tends to offer the most complete removal and the lowest recurrence rates. The tradeoff is a longer recovery and the need for sutures near the eye.
- Darker skin tones: Pigmentation changes are a bigger concern with both chemical peels and lasers. The Er:YAG laser may carry less pigmentation risk than the COâ‚‚ laser, and surgical excision avoids the issue of thermal damage to surrounding skin entirely.
- Recurrent deposits: If you have already had one round of treatment and the xanthelasma has returned, consider switching to a different modality or opting for deeper surgical excision. Combining treatment with lipid management, even if it does not guarantee the deposits will stay away, addresses the metabolic driver.
Whichever route you choose, ask your practitioner specifically about their recurrence rates and their experience treating xanthelasma. The eyelid is delicate territory. Ectropion, a condition where the lower lid turns outward, is a feared complication of aggressive treatment, though it is uncommon in skilled hands.
Cosmetic Camouflage as a Bridge
While you are deciding on treatment, or if you have decided to live with smaller deposits, cosmetic camouflage can reduce their visibility. Specialized medical-grade concealers, formulated to be opaque and long-wearing, can temporarily normalize the appearance of skin affected by scarring, pigmentation disorders, or raised lesions like xanthelasma.16Indian Journal of Dermatology, Venereology and Leprology. Skin camouflage therapy These are not the same as everyday concealers; they offer heavier coverage and are designed to stay in place over uneven texture. A dermatologist or medical aesthetician can help match the product to your skin tone and demonstrate application technique for the delicate eyelid area.
Camouflage is purely cosmetic and does nothing to address the deposits themselves or the underlying lipid issues. But for people who are not ready for a procedure, or who are waiting for an appointment, it can make a meaningful difference in self-consciousness and daily comfort. Some patients continue using camouflage even after partial treatment, especially if a small residual patch remains that does not justify another procedure.
The Genetic Angle
Some people develop xanthelasma in their twenties or thirties, while others never develop it despite having high cholesterol for decades. Genetics plays a role beyond just cholesterol levels. The Mendelian randomization study mentioned earlier identified a dozen circulating proteins that are genetically linked to xanthelasma risk, including proteins involved in immune signaling, cell adhesion, and complement activation.3PubMed Central. Causal associations between plasma lipids, metabolic traits, circulating proteins, and xanthelasma palpebrarum: a Mendelian randomization study This means that individual susceptibility involves not just how much cholesterol is circulating in your blood, but how your immune cells respond to lipid deposits in the skin and how readily your eyelid tissue recruits macrophages that become foam cells.
People with familial hypercholesterolemia, an inherited condition causing very high LDL levels from a young age, are especially prone to xanthelasma and may develop large, bilateral deposits that are more difficult to treat.14PubMed. Rapid resolution of xanthelasmas after treatment with alirocumab If you develop xanthelasma before age 40, or if it runs in your family alongside high cholesterol, it is worth asking your doctor about genetic lipid testing. Catching familial hypercholesterolemia early allows for more aggressive lipid lowering that can substantially reduce lifetime heart disease risk, even if it does not reliably clear the eyelid deposits.